| Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease S Romeo, J Kozlitina, C Xing, A Pertsemlidis, D Cox, LA Pennacchio, ... Nature genetics 40 (12), 1461, 2008 | 3310 | 2008 |
| Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects LMS Carlsson, M Peltonen, S Ahlin, Å Anveden, C Bouchard, B Carlsson, ... New England Journal of Medicine 367 (8), 695-704, 2012 | 936 | 2012 |
| Genetics and epigenetics of NAFLD and NASH: Clinical impact M Eslam, L Valenti, S Romeo Journal of hepatology 68 (2), 268-279, 2018 | 825 | 2018 |
| Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL S Romeo, LA Pennacchio, Y Fu, E Boerwinkle, A Tybjaerg-Hansen, ... Nature genetics 39 (4), 513-516, 2007 | 601 | 2007 |
| The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 598 | 2016 |
| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 520 | 2015 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 478 | 2021 |
| Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans S Romeo, W Yin, J Kozlitina, LA Pennacchio, E Boerwinkle, HH Hobbs, ... The Journal of clinical investigation 119 (1), 70-79, 2009 | 463 | 2009 |
| Statin use and non-alcoholic steatohepatitis in at risk individuals P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ... Journal of hepatology 63 (3), 705-712, 2015 | 424 | 2015 |
| Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study C Levy-Marchal, CC Patterson, A Green, Eurodiab Ace Study Group Diabetologia 44, B75-B80, 2001 | 376 | 2001 |
| An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans A Mardinoglu, H Wu, E Bjornson, C Zhang, A Hakkarainen, SM Räsänen, ... Cell metabolism 27 (3), 559-571. e5, 2018 | 356 | 2018 |
| PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ... Human molecular genetics 23 (15), 4077-4085, 2014 | 356 | 2014 |
| Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro C Pirazzi, M Adiels, MA Burza, RM Mancina, M Levin, M Ståhlman, ... Journal of hepatology 57 (6), 1276-1282, 2012 | 289 | 2012 |
| Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver P Dongiovanni, S Stender, A Pietrelli, RM Mancina, A Cespiati, S Petta, ... Journal of internal medicine 283 (4), 356-370, 2018 | 271 | 2018 |
| PNPLA3 I148M polymorphism and progressive liver disease P Dongiovanni, B Donati, R Fares, R Lombardi, RM Mancina, S Romeo, ... World journal of gastroenterology: WJG 19 (41), 6969, 2013 | 260 | 2013 |
| PNPLA3 gene in liver diseases E Trépo, S Romeo, J Zucman-Rossi, P Nahon Journal of hepatology 65 (2), 399-412, 2016 | 259 | 2016 |
| Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans K Sevastianova, A Santos, A Kotronen, A Hakkarainen, J Makkonen, ... The American journal of clinical nutrition 96 (4), 727-734, 2012 | 241 | 2012 |
| Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data E Trépo, P Nahon, G Bontempi, L Valenti, E Falleti, HD Nischalke, ... Hepatology 59 (6), 2170-2177, 2014 | 236 | 2014 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 231 | 2019 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 230 | 2017 |
